Pramipexole: here's the fair price
This is what US pharmacies pay, on average, for pramipexole. Use it to spot a fair cash price, and feel good about asking for one.
Pramipexole 0.125 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Pramipexole 0.125 Mg Tablet. Pharmacies pay about $1.15 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| PRAMIPEXOLE 0.125 MG TABLETGeneric | $0.04 per tablet or capsule | $1.15 | 10/21/2026 |
| PRAMIPEXOLE 0.25 MG TABLETGeneric | $0.04 per tablet or capsule | $1.30 | 10/21/2026 |
| PRAMIPEXOLE 0.5 MG TABLETGeneric | $0.05 per tablet or capsule | $1.65 | 10/21/2026 |
| PRAMIPEXOLE 1.5 MG TABLETGeneric | $0.06 per tablet or capsule | $1.87 | 10/21/2026 |
| PRAMIPEXOLE 0.75 MG TABLETGeneric | $0.07 per tablet or capsule | $1.95 | 10/21/2026 |
| PRAMIPEXOLE 1 MG TABLETGeneric | $0.07 per tablet or capsule | $1.96 | 10/21/2026 |
| PRAMIPEXOLE ER 0.75 MG TABLETGeneric | $0.68 per tablet or capsule | $20.43 | 10/21/2026 |
| PRAMIPEXOLE ER 0.375 MG TABLETGeneric | $0.86 per tablet or capsule | $25.77 | 10/21/2026 |
| PRAMIPEXOLE ER 3 MG TABLETGeneric | $1.53 per tablet or capsule | $45.83 | 10/21/2026 |
| PRAMIPEXOLE ER 1.5 MG TABLETGeneric | $1.58 per tablet or capsule | $47.35 | 10/21/2026 |
| PRAMIPEXOLE ER 2.25 MG TABLETGeneric | $1.62 per tablet or capsule | $48.68 | 10/21/2026 |
| PRAMIPEXOLE ER 4.5 MG TABLETGeneric | $1.73 per tablet or capsule | $51.78 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Pramipexole dihydrochloride extended-release tablets are indicated for the treatment of Parkinson's disease. Pramipexole dihydrochloride extended-release tablet is a non-ergot dopamine agonist indicated for the treatment of Parkinson’s disease (PD) (1)
Common side effects (FDA label)
6 ADVERSE REACTIONS The following adverse reactions are discussed in greater detail in other sections of the labeling: Falling Asleep During Activities of Daily Living and Somnolence [see Warnings and Precautions (5.1) ] Symptomatic Orthostatic Hypotension [see Warnings and Precautions (5.2) ] Impulse Control / Compulsive Behaviors [see Warnings and Precautions (5.3) ] Hallucinations and Psychotic-like Behavior [see Warnings and Precautions (5.4) ] Dyskinesia [see Warnings and Precautions (5.5) ] Postural Deformity [see Warnings and Precautions ( 5.6 ) ] Rhabdomyolysis [see Warnings and...
Drug interactions (from the label)
7 DRUG INTERACTIONS Dopamine antagonists: May diminish the effectiveness of pramipexole (7.1). 7.1 Dopamine Antagonists Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of pramipexole dihydrochloride extended-release tablets.
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS Falling Asleep During Activities of Daily Living: Sudden onset of sleep may occur without warning; advise patients to report symptoms. (5.1) Symptomatic Orthostatic Hypotension: Monitor closely especially during dose escalation. (5.2) Impulse Control/Compulsive Behaviors: Patients may experience compulsive behaviors and other intense urges. (5.3) Hallucinations and Psychotic-like Behavior: May occur; risk increases with age. (5.4) Dyskinesia: May be caused or exacerbated by pramipexole dihydrochloride extended-release. (5.5) Postural Deformity: Consider reducing the dose or discontinuing pramipexole dihydrochloride extended-release tablets if postural deformity...
Source: FDA drug label via openFDA, label effective 2021-08-31. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.